CSS clean seas seafood limited

0.00%

13.5¢

Spot on, and you are right that was the half year. Sales will...

First 4 Last

Share
Profile

Follow
acwbagnall

1,922 Posts.

1504

02/03/20

08:37

Post #: 43248211
Share

Originally posted by Bonnie73: ↑

well that's actually just for the half year, so if they can continue to turn a profit this half then the PE will be 6-8 one would think. And they have $25 mill in cash or thereabouts, as the payout from Skretting is not included in end of year accounts (only received 16th January). So with a market cap of only $61 mill, $49 mill of fish in the sea, growing earnings and cash in the bank, yes I agree it is a very good buy at these prices. Only minor concern short term is coronavirus, as a lot of this fish is sold to restaurants and that segment may be hard hit this year. But with ability to snap freeze and store medium term, any short term disruption in markets should not cause long term problems. My feeling is that people will be nervous about going out and travelling this year, and by the end of the year will be resolved to just get on with their lives as previous. Just my hunch though...

Expand

Spot on, and you are right that was the half year.
Sales will definitely take a dive in this half due to coronavirus but by the end of the year things will be more or less back to normal.
I'll be accumulating more shares at this price in the meantime.
Upvote

0 Great analysis

Reply

Top Stories

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

First 4 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 13.5¢		Change 0.000(0.00%)		Mkt cap ! $28.28M

Open	High	Low	Value	Volume
13.5¢	13.5¢	13.5¢	$18.51K	137.1K

Buyers (Bids)

No.	Vol.	Price($)
6	4127350	13.5¢

Sellers (Offers)

Price($)	Vol.	No.
14.0¢	6763916	25

View Market Depth

No.	Vol.	Price($)
6	4127350	0.135
3	77222	0.130
2	42200	0.125
1	7500	0.120
1	7826	0.115

Price($)	Vol.	No.
0.140	6763916	25
0.145	68473	1
0.150	7500	2
0.155	8000	1
0.200	7760	1

Last trade - 15.40pm 27/06/2025 (20 minute delay)

CSS (ASX) Chart

Spot on, and you are right that was the half year. Sales will...

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Monash IVF shares cater 25% – Disaster or deep-value play?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Spot on, and you are right that was the half year. Sales will...

Top Stories

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Monash IVF shares cater 25% – Disaster or deep-value play?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News